Saturday, March 28, 2026

Samsung Bioepis Expands SB15 Eylea Rival: Licensing Pact Targets Global Markets as Original Drug Hits $10.5B Sales

Samsung Bioepis has secured a licensing deal for its ophthalmic treatment SB15, expanding access in international markets outside the US and Canada.

Kim Says “Abandon Hope” North Korea Warns Japan That All Negotiations Are Dead

North Korea criticizes Japan's PM Takaichi, viewing her as insincere in improving relations, while Japan seeks U.S. cooperation for dialogue.

Kim Jong-un, New Year “Celebration Event” Speech… No External·National Defense Message

Kim Jong Un's New Year's speech praised citizens' efforts and achievements, emphasizing unity and a people-first ideology for 2026.

Tag: molecular catalyst

How KAIST’s Quinone-Titanium Catalyst Could Transform Energy Production in 2026

A KAIST research team developed a stable molecular catalyst combining quinone and titanium, enhancing artificial energy production methods.

Top News

- Our Sponsors Ad -

Follow us